Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19427561

Int. J. Radiat. Oncol. Biol. Phys. 2009 Jun 1 74 2 616-22

Download in:

View as

General Info

PMID
19427561